News
-
-
-
PRESS RELEASE
Robust Q3 & 9M 2024 Results(1) - Integration on track
-
-
PRESS RELEASE
THIRD QUARTER RESULTS 2024
-
PRESS RELEASE
RESULTATS AU 30 SEPTEMBRE 2024
-
-
PRESS RELEASE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical revises FY2024 financial forecast, expecting growth in revenue and profit. Core metrics show positive trends. Details on the forecast and reasons for revision provided -
-